CITIC Medical Fund
VC Fund
CITIC Medical Fund is a VC fund focused on Health Care and Biotechnology. CITIC Medical Fundhongxin Yiliao Jijin
- Total investments:
- 9
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries CITIC Medical Fund invests in
Stages CITIC Medical Fund invests in
Countries CITIC Medical Fund invests in
Investment Focus
Industry
- Health Care 6 (67%)
- Biotechnology 3 (33%)
- Medical 2 (22%)
- Health Diagnostics 2 (22%)
- Hospital 1 (11%)
Stage
- Series B 5 (56%)
- Series A 4 (44%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xiaocheng Changnu
|
Xiaocheng Changnu is an elderly care service operator. | $14.5M / Series B / Mar 30, 2026 | |
Jingyi Hesheng
|
Jingyi Hesheng is a traditional Chinese medicine hospital operator that is dedicated to researching experience and treatment plans, as well as integrating traditional Chinese medicine knowledge into reproducible standard treatment protocols using modern technologies. | Series A / Jan 26, 2026 | |
Raisecare
|
Raisecare conducts life science research, manufactures and sells life science goods, and develops vitro diagnostic tools. | $13.7M / Series B / Nov 03, 2023 | |
Aikeda Bio
|
Aikeda Bio provides R&D production, sales and technical services. Its products cover coagulation detection systems, specific protein detection systems, reproductive detection systems and immune detection systems | Series A / Sep 01, 2023 | |
Minghao Technology
|
Minghao Technology is a comprehensive solution provider for optometry. | Series A / Jul 09, 2023 | |
Jyss Bio
|
Jyss Bio is a developer of disposable bioreactors and peripheral equipment. | Series B / Jul 25, 2021 | |
Simcere Pharma
|
Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million. | $93.8M / Series B / Jun 04, 2021 | |
YiChao YiLiao
|
YiChao YiLiao is a developer of minimal invasive surgical instruments. | Series A / Feb 01, 2021 | |
Raynovent
|
Raynovent is a science-driven innovative biotech company. | $39.7M / Series B / Dec 15, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CITIC Medical Fund invest in?
CITIC Medical Fund invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CITIC Medical Fund last invest?
The most recent investment recorded for CITIC Medical Fund closed in Mar 2026. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
